News Lucid Diagnostics Inc.

Equities

LUCD

US54948X1090

Market Closed - Nasdaq Other stock markets 01:30:00 27/04/2024 am IST			5-day change	1st Jan Change
0.6831 ^USD	+1.94%		-14.24%	-51.55%

27/03	Cantor Fitzgerald Trims Price Target on Lucid Diagnostics to $3 From $3.80, Maintains Overweight Rating	MT
26/03	Transcript : Lucid Diagnostics Inc., Q4 2023 Earnings Call, Mar 26, 2024

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lucid Diagnostics : Corporate Presentation - March 2024	03/04	PU
Cantor Fitzgerald Trims Price Target on Lucid Diagnostics to $3 From $3.80, Maintains Overweight Rating	27/03	MT
PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results	27/03	PR
Transcript : Lucid Diagnostics Inc., Q4 2023 Earnings Call, Mar 26, 2024	26/03
Lucid Diagnostics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	26/03	CI
Lucid Diagnostics Inc. Announces Positive Data from the First Prospective Clinical Validation Study of Esoguard Esophageal Precancer Testing in A Screening Population	21/03	CI
Lucid Diagnostics Inc. announced that it has received $18.16 million in funding	13/03	CI
Lucid Diagnostics Provides Update Regarding World Trade Center Health Program	19/02	AQ
Lucid Diagnostics Executes Contract to Provide EsoGuard Esophageal Precancer Testing as a Covered Benefit for 9/11 Responders and Survivors	09/02	AQ
Lucid Diagnostics Inc. Executes Contract to Provide Esoguard® Esophageal Precancer Testing as A Covered Benefit for 9/11 Responders and Survivors	08/02	CI
Transcript : Lucid Diagnostics Inc. - Analyst/Investor Day	13/12
Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Results from Three Clinical Utility Studies	12/12	PR
Lucid Diagnostics Inc. and Pavmed Inc. Announces Peer-Reviewed Publication of Positive Results from Three Clinical Utility Studies	12/12	CI
Transcript : Lucid Diagnostics Inc., Q3 2023 Earnings Call, Nov 14, 2023	14/11
Lucid Diagnostics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
Lucid Diagnostics Inc. Appoints Shaun M. O?Neil as President	14/11	CI
PAVmed to Hold a Business Update Conference Call and Webcast on November 15, 2023	01/11	PR
Lucid Diagnostics Inc. announced that it has received $5 million in funding	01/11	CI
Lucid Diagnostics : Private Placement - Form 8-K	18/23/18	PU
Lucid Diagnostics Inc. announced that it expects to receive $5 million in funding	18/23/18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Lucid Diagnostics Inc.

Equities

LUCD

US54948X1090

Summary

Filters